🇺🇸 Menopur in United States

1,041 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Ovarian Hyperstimulation Syndrome — 184 reports (17.68%)
  2. Drug Ineffective — 157 reports (15.08%)
  3. Injection Site Pain — 136 reports (13.06%)
  4. Headache — 126 reports (12.1%)
  5. Abdominal Distension — 87 reports (8.36%)
  6. Nausea — 82 reports (7.88%)
  7. Inappropriate Schedule Of Drug Administration — 81 reports (7.78%)
  8. Ascites — 72 reports (6.92%)
  9. Fatigue — 60 reports (5.76%)
  10. Abortion Spontaneous — 56 reports (5.38%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Menopur approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Menopur in United States?

Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.